Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is a biomarker exploratory study which is designed to investigate the function and
oxidation of the high density lipoprotein (HDL) (the good cholesterol) in patients with type
2 diabetes mellitus treated with Vitamin E versus placebo and segregated by the type of the
Haptoglobin protein they have in their blood.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Technion, Israel Institute of Technology
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins